James M. Nolan
President and CEO

James M. Nolan is the founder, President and Chief Executive Officer for the Institutes for Pharmaceutical Discovery, L.L.C. (IPD). IPD is the parent company to the Institute for Diabetes Discovery, L.L.C. (IDD) and the Institute for Bioanalytics, L.L.C. (IBA).

With broad career experience in the pharmaceutical industry, Mr. Nolan started The Institutes for Pharmaceutical Discovery in 1995. Mr. Nolan has over 20 years experience in the pharmaceutical industry with expertise in global and corporate marketing, new product discovery and positioning, and international strategic planning. He has extensive expertise in developing therapeutics in the areas of diabetes, AIDS, anti-infectives, allergy, cardiovascular, metabolic and gastroenterologic disease. His experience as a leader in the development of therapies for metabolic diseases during his tenure at Wyeth-Ayerst International lead to IPD¹s flagship institute, The Institute for Diabetes Discovery. At IDD, Mr. Nolan and his science team filed an Investigational New Drug application (IND) for IDD 676, a promising drug for diabetic neuropathy, within 18 months of identifying the compound.

Mr. Nolan is a graduate of Villanova University and resides in Guilford, CT